Summary:- TZIELD is the first disease-modifying therapy in T1D, a life-threatening autoimmune disease In a clinical trial, in Stage 2 T1D patients,…
Summary: Approval based on superior survival outcomes of Libtayo plus chemotherapy, compared to chemotherapy alone, in a patient population with a wide…
Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for…
Summary-The Food and Drug Administration granted accelerated approval to teclistamab-cqyv (Tecvayli, Janssen Biotech, Inc.), the first bispecific B-cell maturation antigen (BCMA)-directed CD3…
GSK plc (LSE/NYSE: GSK) and Tempus, a US-based precision medicine company, have entered into a three-year collaboration agreement that provides GSK with…
2022 Updates – Two new ISO Pesticides Published – Broclozone – Isoxazolidinone Herbicide || Ledprona – RNA biopesticide – GreenLight Biosciences Broclozone…
Next Generation Senza® HFX iQ™ is the First and Only SCS System that Uses Artificial Intelligence to Optimize and Maintain Pain Relief…
Natco Pharma has launched two Chlorantraniliprole (CTPR) pesticide formulated combination products under the brand names: NATVOL: Chlorantraniliprole 8.8% + Thiamethoxam 17.5% SC;…
Nobel Prize 2022: Svante Pääbo was given the award “for his discoveries concerning the genomes of extinct hominins and human evolution,” the…
The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two initial doses followed…